Immunity and immune response, pathology and pathologic changes: Progress and challenges in the immunopathology of yellow fever

Reviews in Medical Virology

Volumn 23, Issue 5, 2013, Pages 305-318

  Quaresma, Juarez A S ^a,d   Pagliari, Carla ^b   Medeiros, Daniele B A ^c   Duarte, Maria I S ^b   Vasconcelos, Pedro F C ^c,d  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

^d UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

AFRICA; APOPTOSIS; CELL DEATH; CELL HYPOXIA; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; FLAVIVIRUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; IMMUNOTHERAPY; LIVER CELL; LIVER INJURY; NECROSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SOUTH AMERICA; YELLOW FEVER;

EID: 84882617470     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1752     Document Type: Review

References (60)

1. Monath TP. Yellow fever: an update. The Lancet Infectious Diseases 2001; 1: 11-20.
2. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K. Yellow fever: a decade of reemergence. Journal of the American Medical Association 1996; 276: 1157-62.
3. Fauquet CM, Fargette D. International Committee on Taxonomy of Viruses and the 3, 142 unassigned species. Virology Journal 2005; 2: 64.
4. WHO. Control of Yellow Fever in Africa. WHO: Geneva, 1985.
5. Mondet B, da Rosa AP, Vasconcelos PF. The risk of urban yellow fever outbreaks in Brazil by dengue vectors. Aedes aegypti and Aedes albopictus. Bulletin de la Societe de Pathologie Exotique 1996; 89: 107-13.
6. Kerr JA. The clinical aspects and diagnosis of yellow fever. In: Yellow Fever, Strode GK (ed.). McGrow-Hill: New York, 1951; 385-425.
7. Vasconcelos PF. Yellow fever. Revista da Sociedade Brasileira de Medicina Tropical 2003; 36: 275-93.
8. Santos F. Dosagem dos Fatores da Coagulação na Febre Amarela. Tese de Doutorado, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 1973.
9. Monath TP. Yellow fever: victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future. The American Journal of Tropical Medicine and Hygiene 1991; 45: 1-43.
10. Quaresma JA, Barros VL, Pagliari C, et al. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology 2006; 345: 22-30.
11. Quaresma JA, Barros VL, Fernandes ER, et al. Immunohistochemical examination of the role of Fas ligand and lymphocytes in the pathogenesis of human liver yellow fever. Virus Research 2006; 116: 91-97.
12. Hudson NP. The pathology of experimental yellow fever in the Macacus rhesus. American Journal of Pathology 1928; 4: 395-429.
13. Councilman WT. Report on etiology and prevention of yellow fever. Public Health Bulletin 1890; 2: 151-59.
14. Vieira WT., Gayotto LC, de Lima CP, de Brito T. Histopathology of the human liver in yellow fever with special emphasis on the diagnostic role of the Councilman body. Histopathology 1983; 7: 195-208.
15. Quaresma JA, Barros VL, Fernandes ER, et al. Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever. Acta Tropica 2005; 94: 116-27.
16. Tesh RB, Guzman H, Travassos da Rosa AP, et al. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. Journal of Infectious Diseases 2001; 183: 1431-36.
17. Xiao SY, Zhang H, Guzman H, Tesh RB. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). II. Pathology. The Journal of Infectious Diseases 2001; 183: 1437-44.
18. Monath TP, Brinker NR, Chandler FW, Kemp GE, Cropp CB. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. The American Journal of Tropical Medicine and Hygiene 1981; 30: 431-43.
19. Hall WC, Crowell TP, Watts DM, et al. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. The American Journal of Tropical Medicine and Hygiene 1991; 45: 408-17.
20. Peters CJ, Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Critical Care Medicine 2002; 30: S268-S273.
21. De la Monte SM, Arcid JM, Moore GW, Hutchins GM. Midzonal necrosis as a pattern of hepatocellular injury after shock. Gastroenterology 1984; 86: 627-31.
22. Quaresma JA, Duarte MI, Vasconcelos PFC. Midzonal lesion in the yellow fever: a specific pattern of liver injury caused by direct virus action and by immune anti-inflammatory response. Medical Hypotheses 2006; 47: 618-21.
23. Quaresma JA, Barros VL, Pagliari C, et al. Hepatocyte lesions and cellular immune response in yellow fever infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101: 161-68.
24. Arzberger S, Hösel M, Protzer U. Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus. Journal of Virology 2010; 84: 11994-12001.
25. Hanafy SM, Shehata OH, Farahat NM. Expression of apoptotic markers BCL-2 and Bax in chronic hepatitis C virus patients. Clinical Biochemistry 2010; 43: 1112-17.
26. Tuboi SH, Costa ZG, Vasconcelos PFC, Hatch D. Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101: 169-75.
27. Dias LB Jr, Alves VA, Kanamura C, Oikawa RT, Wakamatsu A. Fulminant hepatic failure in northern Brazil: morphological, immunohistochemical and pathogenic aspects of Lábrea hepatitis and yellow fever. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101: 831-39.
28. Karoui S, Taieb Jomni M, Bellil K, Haouet S, Boubaker J, Filali A. Steatosis in chronic viral hepatitis C: frequency, risk factors and relationship with fibrosis. La Tunisie Médicale 2008; 86: 670-75.
29. Petta S, Amato M, Cabibi D, et al. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 2010; 52: 1543-52.
30. Holz LE, Bowen DG, Bertolino P. Mechanisms of T cell death in the liver: to Bim or not to Bim? Digestive Diseases 2010; 28: 14-24.
31. Sitia G, Iannacone M, Aiolfi R, et al. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathogens 2011; 7: e1002061.
32. Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. The Surgical Clinics of North America 2010; 90: 665-77.
33. Chen RF, Yang KD, Wang L, Liu JW, Chiu CC, Cheng JT. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101: 1106-1113.
34. Monath TP, Barrett AD. Pathogenesis and pathophysiology of yellow fever. Advances in Virus Research 2003; 60: 343-95.
35. Wyllie AH. Apoptosis: cell death in tissue regulation. The Journal of Pathology 1987; 153: 313-16.
36. Selin LK, Wlodarczyk MF, Kraft AR, et al. Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity 2011; 44: 328-47.
37. Corazza N, Badmann A, Lauer C. Immune cell-mediated liver injury. Seminars in Immunopathology 2009; 31: 267-77.
38. King E, Trabue C, Yin D, Yao ZQ, Moorman JP. Hepatitis C: the complications of immune dysfunction. Expert Review of Clinical Immunology 2007; 3: 145-157.
39. Kurane I, Ennis FE. Immunity and immunopathology in dengue virus infections. Seminars in Immunology 1992; 4: 121-27.
40. Dienes HP, Drebber U. Pathology of immune-mediated liver injury. Digestive Diseases 2010; 28: 57-62.
41. Beck MA. Antioxidants and viral infections: host immune response and viral pathogenicity. Journal of the American College of Nutrition 2001; 20: 384S-88S.
42. Chong DL, Sriskandan S. Pro-inflammatory mechanisms in sepsis. Contributions to Microbiology 2011; 17: 86-107.
43. Basu A, Chaturvedi UC. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunology and Medical Microbiology 2008; 53: 287-99.
44. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Current Opinion in Infectious Diseases 2006; 19: 429-36.
45. Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010; 29: 2309-24.
46. Marin Marin ND, París SC, Vélez VM, Rojas CA, Rojas M, García LF. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis 2010; 90: 252-61.
47. Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. Journal of Gastroenterology and Hepatology 2010; 25: 750-57.
48. Rowan PJ, Dunn NJ, El-Serag HB, Kunik ME. Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. Journal of Viral Hepatitis 2007; 14: 883-89.
49. Brenndörfer ED, Weiland M, Frelin L, et al. Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C. Hepatology 2010; 52: 1553-63.
50. Gonzalvez F, Ashkenazi A. New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 2010; 29: 4752-65.
51. Schuster N, Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell and Tissue Research 2002; 307: 1-14.
52. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. Journal of Leukocyte Biology 2008; 83: 536-45.
53. Nduka OO, Parrillo JE. The pathophysiology of septic shock. Critical Care Clinics 2009; 25: 677-702.
54. Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. Journal of Virology 2006; 80: 10208-17.
55. Halstead HB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239: 447-61.
56. Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. Journal of Virology 1997; 71: 4226-32.
57. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. The American Journal of Tropical Medicine and Hygiene 2000; 63: 71-75.
58. Balsitis SJ, Williams KL, Lachica R, et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathogens 6: e1000790.
59. DeLeve LD. Hepatic microvasculature in liver injury. Seminars in Liver Disease 2007; 27: 390-400.
60. Haasnoot J, Berkhout B. RNAi and cellular miRNAs in infections by mammalian viruses. Methods in Molecular Biology 2011; 721: 23-41.